BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haase K, Offeddu GS, Gillrie MR, Kamm RD. Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model. Adv Funct Mater 2020;30:2002444. [PMID: 33692661 DOI: 10.1002/adfm.202002444] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Straehla JP, Hajal C, Safford HC, Offeddu GS, Boehnke N, Dacoba TG, Wyckoff J, Kamm RD, Hammond PT. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc Natl Acad Sci U S A 2022;119:e2118697119. [PMID: 35648828 DOI: 10.1073/pnas.2118697119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater 2021. [PMID: 34385685 DOI: 10.1038/s41563-021-01057-5] [Reference Citation Analysis]
3 Haase K, Piatti F, Marcano M, Shin Y, Visone R, Redaelli A, Rasponi M, Kamm RD. Physiologic flow-conditioning limits vascular dysfunction in engineered human capillaries. Biomaterials 2021;:121248. [PMID: 34794827 DOI: 10.1016/j.biomaterials.2021.121248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Akinbote A, Beltran-Sastre V, Cherubini M, Visone R, Hajal C, Cobanoglu D, Haase K. Classical and Non-classical Fibrosis Phenotypes Are Revealed by Lung and Cardiac Like Microvascular Tissues On-Chip. Front Physiol 2021;12:735915. [PMID: 34690810 DOI: 10.3389/fphys.2021.735915] [Reference Citation Analysis]
5 Lim J, Ching H, Yoon JK, Jeon NL, Kim Y. Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance. Nano Converg 2021;8:12. [PMID: 33846849 DOI: 10.1186/s40580-021-00261-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kim D, Hwang KS, Seo EU, Seo S, Lee BC, Choi N, Choi J, Kim HN. Vascularized Lung Cancer Model for Evaluating the Promoted Transport of Anticancer Drugs and Immune Cells in an Engineered Tumor Microenvironment. Adv Healthc Mater 2022;:e2102581. [PMID: 35286780 DOI: 10.1002/adhm.202102581] [Reference Citation Analysis]
7 Katz RR, West JL. Reductionist Three-Dimensional Tumor Microenvironment Models in Synthetic Hydrogels. Cancers (Basel) 2022;14:1225. [PMID: 35267532 DOI: 10.3390/cancers14051225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moccia C, Haase K. Engineering Breast Cancer On-chip-Moving Toward Subtype Specific Models. Front Bioeng Biotechnol 2021;9:694218. [PMID: 34249889 DOI: 10.3389/fbioe.2021.694218] [Reference Citation Analysis]
9 Amirghasemi F, Adjei-Sowah E, Pockaj BA, Nikkhah M. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers. Ann Biomed Eng 2021;49:1943-72. [PMID: 33403451 DOI: 10.1007/s10439-020-02704-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hajal C, Offeddu GS, Shin Y, Zhang S, Morozova O, Hickman D, Knutson CG, Kamm RD. Engineered human blood-brain barrier microfluidic model for vascular permeability analyses. Nat Protoc 2022;17:95-128. [PMID: 34997242 DOI: 10.1038/s41596-021-00635-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
11 Wang J, Chen C, Wang L, Xie M, Ge X, Wu S, He Y, Mou X, Ye C, Sun Y. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy. Front Oncol 2022;12:872531. [PMID: 35449581 DOI: 10.3389/fonc.2022.872531] [Reference Citation Analysis]
12 Bae J, Choi YS, Cho G, Jang SJ. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery. Cancers (Basel) 2022;14:2144. [PMID: 35565273 DOI: 10.3390/cancers14092144] [Reference Citation Analysis]
13 Es HA, Cox TR, Sarafraz-Yazdi E, Thiery JP, Warkiani ME. Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs). Cancers (Basel) 2021;13:5118. [PMID: 34680267 DOI: 10.3390/cancers13205118] [Reference Citation Analysis]
14 Kwee BJ, Sung KE. Engineering microenvironments for manufacturing therapeutic cells. Exp Biol Med (Maywood) 2021;246:1845-56. [PMID: 34250847 DOI: 10.1177/15353702211026922] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Lam M, Reales-Calderon JA, Ow JR, Adriani G, Pavesi A. In vitro 3D liver tumor microenvironment models for immune cell therapy optimization. APL Bioeng 2021;5:041502. [PMID: 34632251 DOI: 10.1063/5.0057773] [Reference Citation Analysis]
16 Ewald ML, Chen YH, Lee AP, Hughes CCW. The vascular niche in next generation microphysiological systems. Lab Chip 2021;21:3244-62. [PMID: 34396383 DOI: 10.1039/d1lc00530h] [Reference Citation Analysis]
17 Hwang DG, Choi YM, Jang J. 3D Bioprinting-Based Vascularized Tissue Models Mimicking Tissue-Specific Architecture and Pathophysiology for in vitro Studies. Front Bioeng Biotechnol 2021;9:685507. [PMID: 34136473 DOI: 10.3389/fbioe.2021.685507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kniebs C, Luengen AE, Guenther D, Cornelissen CG, Schmitz-Rode T, Jockenhoevel S, Thiebes AL. Establishment of a Pre-vascularized 3D Lung Cancer Model in Fibrin Gel-Influence of Hypoxia and Cancer-Specific Therapeutics. Front Bioeng Biotechnol 2021;9:761846. [PMID: 34722481 DOI: 10.3389/fbioe.2021.761846] [Reference Citation Analysis]
19 Lee S, Kang H, Park D, Yu J, Koh SK, Cho D, Kim D, Kang K, Jeon NL. Modeling 3D Human Tumor Lymphatic Vessel Network Using High‐Throughput Platform. Advanced Biology 2021;5:2000195. [DOI: 10.1002/adbi.202000195] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wan Z, Zhang S, Zhong AX, Shelton SE, Campisi M, Sundararaman SK, Offeddu GS, Ko E, Ibrahim L, Coughlin MF, Liu T, Bai J, Barbie DA, Kamm RD. A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts. Biomaterials 2021;276:121032. [PMID: 34303155 DOI: 10.1016/j.biomaterials.2021.121032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kim S, Ko J, Lee SR, Park D, Park S, Jeon NL. Anchor-IMPACT: A standardized microfluidic platform for high-throughput antiangiogenic drug screening. Biotechnol Bioeng 2021;118:2524-35. [PMID: 33764506 DOI: 10.1002/bit.27765] [Reference Citation Analysis]
22 Wu Y, Zhou Y, Qin X, Liu Y. From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations. Biomicrofluidics 2021;15:061503. [PMID: 34804315 DOI: 10.1063/5.0062697] [Reference Citation Analysis]
23 Seo S, Nah S, Lee K, Choi N, Kim HN. Triculture Model of In Vitro BBB and its Application to Study BBB‐Associated Chemosensitivity and Drug Delivery in Glioblastoma. Adv Funct Materials 2022;32:2106860. [DOI: 10.1002/adfm.202106860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Lee S, Kim S, Koo DJ, Yu J, Cho H, Lee H, Song JM, Kim SY, Min DH, Jeon NL. 3D Microfluidic Platform and Tumor Vascular Mapping for Evaluating Anti-Angiogenic RNAi-Based Nanomedicine. ACS Nano 2021;15:338-50. [PMID: 33231435 DOI: 10.1021/acsnano.0c05110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
25 Hu Z, Cao Y, Galan EA, Hao L, Zhao H, Tang J, Sang G, Wang H, Xu B, Ma S. Vascularized Tumor Spheroid-on-a-Chip Model Verifies Synergistic Vasoprotective and Chemotherapeutic Effects. ACS Biomater Sci Eng 2022. [PMID: 35167260 DOI: 10.1021/acsbiomaterials.1c01099] [Reference Citation Analysis]
26 Zhuang J, Xia L, Zou Z, Yin J. Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells. Med Oncol 2022;39:52. [PMID: 35150326 DOI: 10.1007/s12032-022-01650-x] [Reference Citation Analysis]
27 Kim S, Park J, Kim J, Jeon JS. Microfluidic Tumor Vasculature Model to Recapitulate an Endothelial Immune Barrier Expressing FasL. ACS Biomater Sci Eng 2021;7:1230-41. [PMID: 33586426 DOI: 10.1021/acsbiomaterials.0c01542] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tian C, Zheng S, Liu X, Kamei KI. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system. J Nanobiotechnology 2022;20:338. [PMID: 35858898 DOI: 10.1186/s12951-022-01552-0] [Reference Citation Analysis]